SCHEMBL22993451

SCHEMBL22993451

CCc1c2c(nn1C)CCN(C)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.41
PDE10A Q9Y233 1/20 0.38
CHRM3 P20309 2/20 0.36
GAA P10253 2/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
ADRA1D P25100 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
F12 P00748 2/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253310 0.81 CYP2C19 (0.38) CYP2C19CHRM3GAACYP1A2POLB
SCHEMBL23921831 0.80 PDE10A (0.35) PDE10AGAACYP1A2POLBDRD2
SCHEMBL14861241 0.78 POLB (0.39) PDE10AGAAPOLBDRD2DRD4
SCHEMBL12871625 0.76 GAA (0.53) PDE10AGAACYP1A2POLBALDH1A1
SCHEMBL15345110 0.76 CYP2C19 (0.44) CYP2C19CHRM3GAACYP1A2POLB
SCHEMBL23921809 0.70 HTR2C (0.38) CHRM3GAACYP1A2POLBF12
SCHEMBL22993455 0.68 CYP2C19 (0.32) CYP2C19GAAPOLBALDH1A1LMNA
SCHEMBL17234811 0.68 PDE10A (0.38) CYP2C19PDE10ACHRM3CYP1A2
SCHEMBL26145772 0.64 C5AR1 (0.42) GAADRD2DRD4DRD3ALDH1A1
SCHEMBL17234815 0.64 GAA (0.34) CYP2C19PDE10ACHRM3GAAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 WO disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 WO disclosed